HYTN Announces Marketing Program

VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical development

Result of General Meeting

THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95 GM RESULTS STATEMENT08 NOVEMBER 2024 The Board of Thames Ventures VCT 2 plc (“the Company”) (“the Board”) is pleased to announce that at the

Scroll to Top